AIM-HI launched the Women’s Venture Competition in 2020, despite the global pandemic. Since then, the Women’s Venture Competition has been empowering female scientist-entrepreneurs in the oncology arena. Through this annual competition, AIM-HI provides critically needed seed funding, important coaching, and continuous access to our global network to highly promising female scientist-entrepreneurs, thus empowering women in oncology and furthering the development of groundbreaking treatments.
Launched in 2019, the BRACE Award was developed by our Hong Kong-based partner organization, the Asian Fund for Cancer Research (AFCR). AIM-HI is now collaborating with AFCR to identify and invest in innovative oncology start-ups that can make an impact for cancers prevent in Asian populations.
Benefits of participating in the competition include:
- Interacting with and receiving valuable feedback from the selection and judging committee members, who are key opinion leaders in the oncology field.
- Top finalists will be awarded honorariums, recognized with certificates, and considered for further investment, subject to rigorous due diligence conducted by our Investment Committee.
- The finalist who passes the due diligence process will be eligible to receive investment from AIM-HI and co-investors; the process itself will also help the company assess and refine its IP and strategy, clinical development plan, and position itself well for other investors.
- The winners will gain recognition and presentation opportunities within the oncology research community, facilitating networking and collaboration opportunities with global cancer experts and investors.